Cargando…
A MIF‐Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2
Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine and atypical chemokine with a key role in inflammatory diseases including atherosclerosis. Key atherogenic functions of MIF are mediated by noncognate interaction with the chemokine receptor CXCR2. The MIF N‐like loop comprisin...
Autores principales: | Krammer, Christine, Kontos, Christos, Dewor, Manfred, Hille, Kathleen, Dalla Volta, Beatrice, El Bounkari, Omar, Taş, Karin, Sinitski, Dzmitry, Brandhofer, Markus, Megens, Remco T. A., Weber, Christian, Schultz, Joshua R., Bernhagen, Jürgen, Kapurniotu, Aphrodite |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049018/ https://www.ncbi.nlm.nih.gov/pubmed/33125165 http://dx.doi.org/10.1002/cbic.202000574 |
Ejemplares similares
-
Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4
por: Lacy, Michael, et al.
Publicado: (2018) -
Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting
por: Kontos, Christos, et al.
Publicado: (2020) -
Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation
por: Brandhofer, Markus, et al.
Publicado: (2022) -
Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis
por: Tillmann, Sabine, et al.
Publicado: (2013) -
Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly
por: Taş, Karin, et al.
Publicado: (2022)